🔎 Trials Near Me

Gara Jalqabaatti › Dhukkubaa Harkaa Steatotic › Arizona › Tucson

Qorannoo klinikaalii Dhukkubaa Harkaa Steatotic Tucson, AZ keessatti

Qorannoo 10 Dhukkubaa Harkaa Steatotic f Tucson fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Namoota walitti qabaa jiraSadarkaa 3
  • 89bio Clinical Study Site, Tucson
  • 89bio Clinical Study Site, Tucson
  • 89bio Clinical Study Site, Tucson
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Namoota walitti qabaa jiraSadarkaa 3
  • 89bio Clinical Study Site, Tucson
  • 89bio Clinical Study Site, Tucson
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06318169

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Namoota walitti qabaa jiraSadarkaa 2
  • Arizona Liver Health - Tucson, Tucson
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07527910

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Namoota walitti qabaa jiraSadarkaa 2
  • Adobe Clinical Research, Tucson
  • Arizona Liver Health - Tucson, Tucson
  • Del Sol Research Management, LLC, Tucson
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Namoota walitti qabaa jiraSadarkaa 3
  • The Institute for Liver Health II dba Arizona Clinical Trials - Tucson, Tucson
  • Del Sol Research Management, LLC, Tucson
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Namoota walitti qabaa jiraSadarkaa 3
  • Akero Clinical Study Site, Tucson
  • Akero Clinical Study Site, Tucson
  • Akero Clinical Study Site, Tucson
  • fi 1 dabalataa
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06528314

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Namoota walitti qabaa jiraSadarkaa 2
  • Adobe Clinical Research, LLC, Tucson
  • Arizona Liver Health - Tucson, Tucson
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07288138

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Namoota walitti qabaa jiraSadarkaa 2
  • GSK Investigational Site, Tucson
  • GSK Investigational Site, Tucson
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Namoota walitti qabaa jiraSadarkaa 3
  • GSK Investigational Site, Tucson
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Namoota walitti qabaa jiraSadarkaa 2
  • GSK Investigational Site, Tucson
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 08-Ado-2026 · NCT06920043

Qorannoo Dhukkubaa Harkaa Steatotic magaalota biroo keessatti

Qorannoo biroo Tucson keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.